Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

GE HealthCare Technologies Inc. GEHC

Healthcare  —  Medical Devices
66.63 0.25 0.38% as of 25 Sep
Market cap
$29.9B
P/E
15.3×
S&P 500 Member Dividend Champion (3y) Revenue Champion (5y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

GE HealthCare Technologies Inc. (GEHC) EV/EBITDA

As of 25 September 2026, GE HealthCare Technologies Inc. (GEHC) trades at a EV/EBITDA of 11.9×. Over the past ten years it has ranged from 0.0× (December 2022) to 16.8× (March 2024); the current reading is higher than 13% of that period. That is in line with the Medical Devices industry median of 11.8× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 13.3× (1.10%)
FY2024 13.5× (4.93%)
FY2023 14.2× 38.90%
FY2022 10.2× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly

Period EV/EBITDA Change
Jun 2026 11.5× (10.61%)
Mar 2026 12.9× (3.59%)
Dec 2025 13.3× 4.97%
Sep 2025 12.7× 1.31%
14 more quarters

Against its own ten years

Low 0.0× High 16.8×
Ten-year median 13.2×
Current reading's percentile 13

EV/EBITDA against peers

Company EV/EBITDA
SNN Smith & Nephew SNATS, Inc. compare 5.7×
PHG Koninklijke Philips N.V. compare 8.6×
ZBH Zimmer Biomet Holdings, Inc. compare 10.6×
GEHC GE HealthCare Technologies Inc. 11.9×
STE STERIS plc compare 13.4×
BSX Boston Scientific Corporation compare 13.8×
DXCM DexCom, Inc. compare 23.2×
EW Edwards Lifesciences Corporation compare 28.6×
PEN Penumbra, Inc. compare 58.2×
Medical Devices industry median 11.8×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on GEHC